tomatine has been researched along with Ovarian Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, Z; Huang, S; Li, W; Liu, C; Rong, Y; Wang, T; Wu, H; Wu, Z; Zhang, L | 1 |
| Bettis, S; Boxer, MB; Chiang, CY; Curtis, M; Ferrer, M; Jadhav, A; Kenny, HA; Lal-Nag, M; Lengyel, E; Li, Z; Mitra, AK; Schryver, EM; Shen, M; White, EA; Zhang, Y | 1 |
2 other study(ies) available for tomatine and Ovarian Neoplasms
| Article | Year |
|---|---|
α-Tomatine, a novel early-stage autophagy inhibitor, inhibits autophagy to enhance apoptosis via Beclin-1 in Skov3 cells.
Topics: Apoptosis; Autophagy; Beclin-1; Cell Line, Tumor; Female; Humans; Molecular Structure; Ovarian Neoplasms; Signal Transduction; Solanum lycopersicum; Tomatine | 2021 |
Quantitative high throughput screening using a primary human three-dimensional organotypic culture predicts in vivo efficacy.
Topics: Animals; Antineoplastic Agents; Benzophenanthridines; Biguanides; Cantharidin; Cell Adhesion; Cell Movement; Cell Proliferation; Coculture Techniques; Epithelial Cells; Escin; Extracellular Matrix; Female; Fibroblasts; High-Throughput Screening Assays; Humans; Inhibitory Concentration 50; Isoquinolines; Mice; Mice, Nude; Ovarian Neoplasms; Primary Cell Culture; Prochlorperazine; Tomatine; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2015 |